Publication:
The role of ruxolitinib treatment in JAK-mutated Ph-like acute lymphoblastic leukemia

Simple item page
dc.contributor.authorDEMİRTAŞ, DERYA
dc.contributor.authorYANIK, AHMET MERT
dc.contributor.authorATAGÜNDÜZ, IŞIK
dc.contributor.authorTOPTAŞ, TAYFUR
dc.contributor.authorsCandan O., Demirtas D., YANIK A. M., ATAGÜNDÜZ I., TOPTAŞ T.
dc.date.accessioned2023-10-03T10:31:05Z
dc.date.accessioned2026-01-11T19:16:18Z
dc.date.available2023-10-03T10:31:05Z
dc.date.issued2023-01-01
dc.identifier.citationCandan O., Demirtas D., YANIK A. M., ATAGÜNDÜZ I., TOPTAŞ T., "The role of ruxolitinib treatment in JAK-mutated Ph-like acute lymphoblastic leukemia", Annals of Hematology, 2023
dc.identifier.doi10.1007/s00277-023-05456-3
dc.identifier.issn0939-5555
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85171590640&origin=inward
dc.identifier.urihttps://hdl.handle.net/11424/294248
dc.language.isoeng
dc.relation.ispartofAnnals of Hematology
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectTıp
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectHematoloji
dc.subjectSağlık Bilimleri
dc.subjectMedicine
dc.subjectInternal Medicine Sciences
dc.subjectInternal Diseases
dc.subjectHematology
dc.subjectHealth Sciences
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectHEMATOLOJİ
dc.subjectClinical Medicine (MED)
dc.subjectCLINICAL MEDICINE
dc.subjectHEMATOLOGY
dc.titleThe role of ruxolitinib treatment in JAK-mutated Ph-like acute lymphoblastic leukemia
dc.typearticle
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
file.pdf
Size:
357.65 KB
Format:
Adobe Portable Document Format
Download

Collections

Araştırma Çıktıları